70 participants
CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-11
- Start Date:
- 2022-03-08
- Completion:
- 2025-03-31
Conditions
- Multiple Sclerosis
Interventions
- DRUG
No Results Yet